Volume 2(Supplement 1):46-49 Working together: establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka by P. Abeysinghe, L. Morawaka, S. Gunasekara, S. Suresh, P. H. S. P. Udara, P. P. R. Siriwardena, S. Milliken, D. D. F. Ma, and J. Moore BloodAdv Volume 2(Supplement 1):46-49 November 30, 2018 © 2018 by The American Society of Hematology

Map of Sri Lanka showing location of the NCI. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

NCI team with Dr. Moore while in training at SVH. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

The first patient at apheresis. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

Staff discussing procedure with first patient. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

Apheresis machine. Apheresis machine. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

First patient after engraftment. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

Cancer incidence data from Sri Lanka's National Cancer Control Programme. Cancer incidence data from Sri Lanka's National Cancer Control Programme. ASR, age-specific rate. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

Disease percentage among patients at National Cancer Institute, Sri Lanka, during the first year. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

Age groups of patients with autologous HSCT. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology

HSCT development timeline at NCI. P. Abeysinghe et al. Blood Adv 2018;2:46-49 © 2018 by The American Society of Hematology